Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Edgewise Therapeutics Inc.
Sponsor

Edgewise Therapeutics Inc.

United States 1715 38th Street, 80301-2603, United States

About the sponsor

Edgewise Therapeutics Inc. focuses on Becker muscular dystrophy, including BMD in both adult and adolescent populations, with additional interest in related limb-girdle muscular dystrophy subtypes.

  • Becker muscular dystrophy
  • Adolescent neuromuscular disease
  • Limb-girdle muscular dystrophy

The sponsored studies examine muscle integrity, skeletal muscle function, and markers linked to muscle damage in these inherited disorders.

About Specializations

Edgewise Therapeutics Inc. runs clinical trials in conditions such as Becker's muscular dystrophy, Glycogen storage disease type V, Muscular dystrophy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Becker's muscular dystrophy

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Edg-5506
  • Sponsor:Edgewise Therapeutics Inc.

Glycogen storage disease type V+2

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Edg-5506
  • Sponsor:Edgewise Therapeutics Inc.

Becker's muscular dystrophy

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Edg-5506
  • Sponsor:Edgewise Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.